Mogamulizumab for the treatment of T-cell lymphoma

Makita, S; Tobinai, K

Makita, S (reprint author), Natl Canc Ctr, Dept Hematol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.

EXPERT OPINION ON BIOLOGICAL THERAPY, 2017; 17 (9): 1145

Abstract

Introduction: T-cell lymphoma is a relatively rare hematologic malignancy that accounts for 10-20% of non-Hodgkin lymphomas. Treatment strategies for ......

Full Text Link